Epicareer Might not Working Properly
Learn More
Back

Qiming Venture Partners

Founded by : -, 1 January 2006

Hong Kong Central, Hong Kong SAR China
N/A
51 to 200 employees

About the Company

Founded in 2006, Qiming Venture Partners is a leading venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China and Singapore. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages. Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or by other means. There are also over 70 portfolio companies that have achieved unicorn status. Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi (SEHK:1810), Meituan (SEHK:3690), Bilibili (NASDAQ:BILI, SEHK:9626), Zhihu (NYSE: ZH, SEHK: 2390), Roborock (SHSE:688169), Gan & Lee Pharmaceuticals (SHSE: 603087), Tigermed (SZSE:300347, SEHK:3347), Zai Lab (NASDAQ:ZLAB, SEHK:9688), CanSino Biologics (SEHK:6185, SHSE:688185), Schrödinger (NASDAQ:SDGR), APT Medical (SHSE:688617), New Horizon Health (SEHK:6606), Sanyou Medical (SHSE:688085), AmoyDx (SZSE:300685), Berry Genomics (SZSE:000710), SinocellTech (SHSE: 688520), UBTech (SEHK:9880), Yuanxin Technology, Caidya, Belief BioMed, WeRide, Biren Technology, among many others.

Industry Type

According to the GICS (Global Industry Classification Standard) version of March 2023, Qiming Venture Partners’s industry classification falls within the following categories:
  • Sector: -
  • Industry group: -
  • Industry: -
  • Sub-Industry: -
Videos and Photos

Company Address

16/F, V Point, 18 Tang Lung St, Causeway Bay, Hong Kong

Source : Google maps